EC Number |
Inhibitors |
Structure |
---|
2.4.2.29 | 2,3-Dihydroxybenzoic acid |
- |
|
2.4.2.29 | 2,6-bis(methylamino)-1,4a,7,8a-tetrahydro-8H-imidazo[4,5-g]quinazolin-8-one |
- |
|
2.4.2.29 | 2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one |
- |
|
2.4.2.29 | 2,6-diamino-8-(2-phenylethyl)quinazolin-4(3H)-one |
- |
|
2.4.2.29 | 2,6-diaminoquinazolin-4(3H)-one |
- |
|
2.4.2.29 | 2-(methylamino)-1,4a,7,8a-tetrahydro-8H-imidazo[4,5-g]quinazolin-8-one |
- |
|
2.4.2.29 | 2-([2-(morpholin-4-yl)ethyl]amino)-1,4a,7,8a-tetrahydro-8H-imidazo[4,5-g]quinazolin-8-one |
- |
|
2.4.2.29 | 2-amino-5-(fluoromethyl)pyrrolo[2,3-d]pyrimidin-4(3H)-one |
inactivation and competitive inhibition. 2-amino-5-(fluoromethyl)pyrrolo[2,3-d]pyrimidin-4(3H)-one appears to partition between: 1. normal turnover, 2. inactivation, 3. an alternative processing to an unidentrified fluoride-released product |
|
2.4.2.29 | 2-amino-7-(dimethylamino)quinazolin-4(3H)-one |
- |
|
2.4.2.29 | 2-amino-7-[benzyl(methyl)amino]quinazolin-4(3H)-one |
- |
|